Date | Opp | DKSAL | FDSAL | DKFPTS | FDFPTS | min | fg% | fgm | fga | ftm | dd | fta | tfoul | 3pm | usg | 3pa | 3p% | 2pm | 2pa | pfoul | reb | ffoul | ast | fouls | stl | pace | blk | ft% | to | 2p% | pts | td | oreb |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-03-10 | @ CHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-03-08 | vs. SAS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-03-07 | vs. DEN | -- | -- | 0 | 0 | 4.17 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9.59 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-03-04 | vs. BOS | $3.1K | $3.5K | 9 | 8.8 | 14.2 | 0.4 | 2 | 5 | 0 | 0 | 1 | 0 | 0 | 15.32 | 0 | 0 | 2 | 5 | 2 | 4 | 0 | 0 | 2 | 0 | 2.5 | 0 | 0 | 0 | 0.4 | 4 | 0 | 3 |
2020-03-02 | vs. UTA | $3K | $3.5K | 8.5 | 8.4 | 17.3 | 0.43 | 3 | 7 | 0 | 0 | 2 | 0 | 0 | 18.22 | 0 | 0 | 3 | 7 | 2 | 2 | 0 | 0 | 2 | 0 | 7 | 0 | 0 | 0 | 0.43 | 6 | 0 | 1 |
2020-02-29 | vs. IND | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-28 | @ NOP | $3K | $3.5K | 10.25 | 9.6 | 9.95 | 0.67 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 18.73 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 1 | 0.67 | 4 | 0 | 0 |
2020-02-26 | vs. PHI | $3K | $3.5K | 11 | 10.9 | 7.2 | 0.75 | 3 | 4 | 0 | 0 | 0 | 0 | 0 | 35.17 | 0 | 0 | 3 | 4 | 2 | 2 | 0 | 1 | 2 | 0 | 6 | 1 | 0 | 2 | 0.75 | 6 | 0 | 0 |
2020-02-24 | vs. MIA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-22 | @ MIA | $3K | $3.6K | 8 | 8 | 8.58 | 1 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 25.36 | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 5.5 | 0 | 1 | 2 | 1 | 7 | 0 | 0 |
2020-02-21 | @ WAS | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-12 | vs. ATL | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-09 | vs. LAC | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-05 | @ OKC | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-03 | vs. NYK | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-02-01 | vs. GSW | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-30 | vs. TOR | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-28 | vs. NOP | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-27 | @ DET | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-25 | vs. CHI | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-23 | vs. WAS | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-20 | vs. NYK | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-18 | @ CHI | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-17 | @ MEM | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-14 | @ LAC | $3.1K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-13 | @ LAL | $3.2K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2020-01-11 | @ DEN | $3.4K | $3.6K | 9.5 | 9.2 | 9.57 | 0.33 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 12.54 | 0 | 0 | 1 | 3 | 3 | 6 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0.33 | 2 | 0 | 1 |
2020-01-09 | @ DET | $3.9K | $3.6K | 6.75 | 7.7 | 7.35 | 0.33 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 18.12 | 0 | 0 | 1 | 3 | 2 | 1 | 0 | 1 | 2 | 1 | 3 | 0 | 0 | 0 | 0.33 | 2 | 0 | 0 |
2020-01-07 | vs. DET | $4.6K | $3.5K | 19.75 | 20.8 | 16.27 | 0.67 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 10.92 | 0 | 0 | 2 | 3 | 1 | 9 | 0 | 0 | 1 | 1 | 3.5 | 1 | 1 | 1 | 0.67 | 5 | 0 | 1 |
2020-01-05 | vs. MIN | $3K | $3.5K | 35 | 32.4 | 24.58 | 0.86 | 6 | 7 | 3 | 1 | 4 | 0 | 0 | 20.21 | 0 | 0 | 6 | 7 | 2 | 12 | 0 | 2 | 2 | 1 | 8 | 0 | 0.75 | 3 | 0.86 | 15 | 0 | 4 |
2020-01-04 | vs. OKC | $3K | $3.5K | 4.5 | 5.4 | 3.15 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 25.4 | 0 | 0 | 0 | 2 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
2020-01-02 | vs. CHA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-31 | @ TOR | $3K | $3.5K | 0 | 0 | 2.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-28 | @ MIN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-27 | @ BOS | $1.5K | $6K | 12.5 | 13.4 | 4.92 | 1 | 2 | 2 | 4 | 0 | 4 | 0 | 0 | 30.57 | 0 | 0 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 0 | 4 | 1 | 1 | 0 | 1 | 8 | 0 | 0 |
2019-12-23 | vs. ATL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-20 | vs. MEM | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-18 | vs. CHA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-16 | @ TOR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-14 | @ MIL | $3K | $3.5K | 8.5 | 8.4 | 5.63 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 21.31 | 0 | 0 | 3 | 3 | 1 | 2 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 1 | 6 | 0 | 0 |
2019-12-12 | @ SAS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-11 | vs. HOU | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-09 | @ BOS | $3K | $3.5K | 2 | 3 | 2.55 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 31.37 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-07 | @ PHI | $3K | $3.5K | 12 | 12.8 | 12 | 0.67 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 11.47 | 0 | 0 | 2 | 3 | 1 | 4 | 0 | 0 | 1 | 1 | 2.5 | 0 | 1 | 0 | 0.67 | 5 | 0 | 1 |
2019-12-06 | vs. ORL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-12-03 | vs. DET | $3K | $3.5K | 4.5 | 4.4 | 3.82 | 0.33 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 31.41 | 0 | 0 | 1 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0.33 | 2 | 0 | 1 |
2019-11-29 | vs. MIL | $3K | $3.5K | 1.25 | 1.2 | 2.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-27 | vs. ORL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-25 | vs. BKN | $3.2K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-23 | vs. POR | $3.4K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-22 | @ DAL | $3.7K | $3.5K | 12.75 | 13.6 | 12 | 0.6 | 3 | 5 | 1 | 0 | 1 | 0 | 0 | 18.13 | 0 | 0 | 3 | 5 | 1 | 3 | 0 | 0 | 1 | 1 | 4.5 | 0 | 1 | 0 | 0.6 | 7 | 0 | 1 |
2019-11-20 | @ MIA | $3.4K | $3.5K | 9.25 | 8.6 | 14.78 | 0.67 | 2 | 3 | 2 | 0 | 2 | 0 | 0 | 13.21 | 0 | 0 | 2 | 3 | 3 | 3 | 0 | 0 | 3 | 0 | 3 | 0 | 1 | 1 | 0.67 | 6 | 0 | 2 |
2019-11-18 | @ NYK | $3K | $3.5K | 12.5 | 12.2 | 20.4 | 0.5 | 2 | 4 | 1 | 0 | 2 | 0 | 0 | 9.57 | 0 | 0 | 2 | 4 | 3 | 6 | 0 | 0 | 3 | 0 | 4 | 0 | 0.5 | 0 | 0.5 | 5 | 0 | 1 |
2019-11-17 | vs. PHI | $3K | $3.5K | 10.5 | 11.4 | 16.63 | 0.5 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 14.43 | 0 | 0 | 3 | 6 | 1 | 2 | 0 | 0 | 1 | 0 | 5 | 1 | 0 | 0 | 0.5 | 6 | 0 | 1 |
2019-11-14 | vs. MIA | $1.5K | $8.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-12 | @ PHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-10 | @ NYK | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-08 | @ WAS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-05 | vs. BOS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-03 | vs. DAL | $3.1K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-11-01 | @ IND | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-30 | vs. CHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-28 | @ MIL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-26 | vs. IND | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-23 | @ ORL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-15 | vs. BOS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-13 | @ BOS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-11 | @ DET | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-10-07 | vs. SLA | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-09 | vs. CHA | -- | -- | 12.5 | 12.3 | 21.37 | 0.5 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 11.85 | 0 | 0 | 3 | 6 | 2 | 4 | 0 | 1 | 2 | 0 | 4 | 0 | 0 | 0 | 0.5 | 6 | 0 | 2 |
2019-04-07 | vs. SAS | -- | -- | 23 | 21.2 | 16.97 | 0.83 | 5 | 6 | 4 | 0 | 5 | 0 | 0 | 27.96 | 0 | 0 | 5 | 6 | 0 | 6 | 0 | 2 | 0 | 0 | 7.5 | 0 | 0.8 | 3 | 0.83 | 14 | 0 | 4 |
2019-04-05 | @ GSW | -- | -- | 19.5 | 19.2 | 16.77 | 0.5 | 4 | 8 | 4 | 0 | 4 | 0 | 0 | 23.28 | 0 | 0 | 4 | 8 | 1 | 6 | 0 | 0 | 1 | 0 | 7 | 0 | 1 | 0 | 0.5 | 12 | 0 | 3 |
2019-04-04 | @ SAC | -- | -- | 33.5 | 30 | 30.82 | 0.78 | 7 | 9 | 0 | 1 | 2 | 0 | 0 | 21.03 | 0 | 0 | 7 | 9 | 1 | 10 | 0 | 4 | 1 | 0 | 13 | 1 | 0 | 5 | 0.78 | 14 | 0 | 2 |
2019-04-01 | @ PHX | -- | -- | 28.75 | 29.4 | 13.88 | 0.83 | 5 | 6 | 5 | 0 | 9 | 0 | 0 | 30.61 | 0 | 0 | 5 | 6 | 3 | 7 | 0 | 2 | 3 | 0 | 5.5 | 1 | 0.56 | 0 | 0.83 | 15 | 0 | 5 |
2019-03-30 | @ LAC | -- | -- | 6.5 | 6.4 | 6.8 | 0.67 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 17.65 | 0 | 0 | 2 | 3 | 2 | 2 | 0 | 0 | 2 | 0 | 3 | 0 | 0 | 0 | 0.67 | 4 | 0 | 0 |
2019-03-28 | @ SAS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-03-26 | vs. BOS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-03-24 | @ MIL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-03-22 | vs. LAC | -- | -- | 7.75 | 7.6 | 13.92 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 13.39 | 0 | 0 | 0 | 2 | 2 | 3 | 0 | 2 | 2 | 0 | 4 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
2019-03-20 | vs. MIL | -- | -- | 27.5 | 29 | 25.03 | 0.5 | 3 | 6 | 2 | 0 | 4 | 0 | 0 | 13.46 | 0 | 0 | 3 | 6 | 3 | 10 | 0 | 2 | 3 | 0 | 2 | 2 | 0.5 | 0 | 0.5 | 8 | 0 | 6 |
2019-03-18 | vs. DET | -- | -- | 18.5 | 18.7 | 25.03 | 0.4 | 2 | 5 | 4 | 0 | 6 | 0 | 0 | 14.33 | 0 | 0 | 2 | 5 | 4 | 6 | 0 | 1 | 4 | 1 | 9 | 0 | 0.67 | 1 | 0.4 | 8 | 0 | 0 |
2019-03-16 | @ DAL | -- | -- | 20.75 | 19.5 | 30.82 | 0.8 | 4 | 5 | 3 | 0 | 3 | 0 | 0 | 12.08 | 0 | 0 | 4 | 5 | 4 | 5 | 0 | 3 | 4 | 0 | 6.5 | 0 | 1 | 2 | 0.8 | 11 | 0 | 2 |
2019-03-14 | @ ORL | -- | -- | 22.5 | 22.1 | 29.98 | 0.45 | 5 | 11 | 1 | 0 | 1 | 0 | 0 | 15.7 | 0 | 0 | 5 | 11 | 2 | 8 | 0 | 1 | 2 | 0 | 9.5 | 0 | 1 | 0 | 0.45 | 11 | 0 | 2 |
2019-03-12 | @ PHI | -- | -- | 20.25 | 19 | 34.17 | 0.5 | 6 | 12 | 0 | 0 | 1 | 0 | 0 | 17.68 | 0 | 0 | 6 | 12 | 2 | 5 | 0 | 2 | 2 | 0 | 11.5 | 0 | 0 | 2 | 0.5 | 12 | 0 | 3 |
2019-03-11 | vs. TOR | -- | -- | 24.25 | 22.4 | 26.9 | 0.67 | 8 | 12 | 1 | 0 | 1 | 0 | 0 | 22.96 | 0 | 0 | 8 | 12 | 1 | 7 | 0 | 0 | 1 | 0 | 12.5 | 0 | 1 | 3 | 0.67 | 17 | 0 | 3 |
2019-03-08 | @ MIA | -- | -- | 16.5 | 16.7 | 14.83 | 0.67 | 2 | 3 | 2 | 0 | 4 | 0 | 0 | 16.43 | 0 | 0 | 2 | 3 | 1 | 6 | 0 | 1 | 1 | 1 | 6 | 0 | 0.5 | 1 | 0.67 | 6 | 0 | 0 |
2019-03-06 | @ BKN | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-03-03 | vs. ORL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-03-02 | vs. DET | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-02-28 | @ NYK | -- | -- | 16.25 | 15 | 26.47 | 0.5 | 3 | 6 | 2 | 0 | 4 | 0 | 0 | 15.75 | 0 | 0 | 3 | 6 | 2 | 5 | 0 | 2 | 2 | 0 | 7 | 0 | 0.5 | 2 | 0.5 | 8 | 0 | 3 |
2019-02-25 | vs. POR | -- | -- | 10 | 9.3 | 21.78 | 0.4 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 11.63 | 0 | 0 | 2 | 5 | 1 | 4 | 0 | 1 | 1 | 0 | 5 | 0 | 0 | 1 | 0.4 | 4 | 0 | 1 |
2019-02-23 | vs. MEM | -- | -- | 26.75 | 24.9 | 29.67 | 0.86 | 6 | 7 | 6 | 0 | 7 | 0 | 0 | 18.08 | 0 | 0 | 6 | 7 | 4 | 7 | 0 | 1 | 4 | 0 | 11.5 | 0 | 0.86 | 3 | 0.86 | 18 | 0 | 2 |
2019-02-21 | vs. PHX | -- | -- | 38 | 37.9 | 25.85 | 0.78 | 7 | 9 | 1 | 1 | 2 | 0 | 0 | 18.89 | 0 | 0 | 7 | 9 | 3 | 12 | 0 | 1 | 3 | 1 | 8 | 2 | 0.5 | 2 | 0.78 | 15 | 0 | 4 |
2019-02-13 | vs. BKN | -- | -- | 16.5 | 16.7 | 30.12 | 0.4 | 2 | 5 | 2 | 0 | 2 | 0 | 0 | 9.58 | 0 | 0 | 2 | 5 | 6 | 6 | 0 | 1 | 6 | 1 | 5 | 0 | 1 | 1 | 0.4 | 6 | 0 | 2 |
2019-02-11 | vs. NYK | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-02-09 | @ IND | -- | -- | 7.75 | 7.1 | 16.53 | 0.25 | 1 | 4 | 1 | 0 | 2 | 0 | 0 | 15.03 | 0 | 0 | 1 | 4 | 2 | 3 | 0 | 1 | 2 | 0 | 5 | 0 | 0.5 | 1 | 0.25 | 3 | 0 | 1 |
2019-02-08 | @ WAS | -- | -- | 9.25 | 10.2 | 16.43 | 0.75 | 3 | 4 | 0 | 0 | 0 | 0 | 0 | 9.74 | 0 | 0 | 3 | 4 | 1 | 1 | 0 | 0 | 1 | 0 | 4 | 1 | 0 | 0 | 0.75 | 6 | 0 | 0 |
2019-02-05 | vs. BOS | -- | -- | 24.5 | 23.9 | 22.73 | 0.43 | 3 | 7 | 2 | 0 | 2 | 0 | 0 | 14.45 | 0 | 0 | 3 | 7 | 2 | 12 | 0 | 1 | 2 | 0 | 5 | 0 | 1 | 0 | 0.43 | 8 | 0 | 3 |
2019-02-02 | vs. DAL | -- | -- | 16.5 | 16.2 | 20.07 | 0.44 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 21.92 | 0 | 0 | 4 | 9 | 4 | 6 | 0 | 0 | 4 | 1 | 8 | 0 | 0 | 2 | 0.44 | 8 | 0 | 3 |
2019-01-29 | vs. WAS | -- | -- | 29 | 25.9 | 23.48 | 0.6 | 6 | 10 | 0 | 1 | 0 | 0 | 0 | 21.01 | 0 | 0 | 6 | 10 | 1 | 12 | 0 | 1 | 1 | 0 | 9 | 0 | 0 | 2 | 0.6 | 12 | 0 | 3 |
2019-01-27 | @ CHI | -- | -- | 34 | 35.3 | 35.78 | 0.36 | 4 | 11 | 0 | 0 | 0 | 0 | 0 | 13.4 | 0 | 0 | 4 | 11 | 3 | 14 | 0 | 3 | 3 | 1 | 8 | 1 | 0 | 0 | 0.36 | 8 | 0 | 3 |
2019-01-25 | vs. MIA | -- | -- | 27.25 | 28.3 | 26.93 | 0.57 | 4 | 7 | 3 | 0 | 4 | 0 | 0 | 14.99 | 0 | 0 | 4 | 7 | 3 | 9 | 0 | 1 | 3 | 1 | 8 | 1 | 0.75 | 1 | 0.57 | 11 | 0 | 2 |
2019-01-23 | @ BOS | -- | -- | 26.5 | 23.6 | 32.57 | 0.53 | 9 | 17 | 1 | 0 | 3 | 0 | 0 | 28.64 | 0 | 0 | 9 | 17 | 2 | 8 | 0 | 0 | 2 | 0 | 17.5 | 0 | 0.33 | 5 | 0.53 | 19 | 0 | 6 |
2019-01-21 | vs. CHI | -- | -- | 30.75 | 31.8 | 28.37 | 0.57 | 4 | 7 | 5 | 0 | 6 | 0 | 0 | 15.93 | 0 | 0 | 4 | 7 | 5 | 9 | 0 | 2 | 5 | 1 | 10 | 1 | 0.83 | 1 | 0.57 | 13 | 0 | 1 |
2019-01-19 | @ DEN | -- | -- | 30.5 | 30.2 | 30.77 | 0.75 | 9 | 12 | 5 | 0 | 6 | 0 | 0 | 19.03 | 0 | 0 | 9 | 12 | 2 | 6 | 0 | 0 | 2 | 0 | 15 | 0 | 0.83 | 0 | 0.75 | 23 | 0 | 0 |
2019-01-18 | @ UTA | -- | -- | 33 | 33 | 34.4 | 0.58 | 7 | 12 | 1 | 1 | 2 | 0 | 0 | 14.98 | 0 | 0 | 7 | 12 | 3 | 10 | 0 | 0 | 3 | 1 | 11 | 1 | 0.5 | 0 | 0.58 | 15 | 0 | 2 |
2019-01-16 | @ POR | -- | -- | 31.5 | 33.1 | 26.53 | 0.63 | 5 | 8 | 6 | 0 | 7 | 0 | 0 | 17.2 | 0 | 0 | 5 | 8 | 2 | 8 | 0 | 1 | 2 | 0 | 8.5 | 2 | 0.86 | 0 | 0.63 | 16 | 0 | 3 |
2019-01-13 | @ LAL | -- | -- | 6.5 | 6.3 | 10.43 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5.1 | 0 | 0 | 0 | 1 | 2 | 4 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
2019-01-11 | @ HOU | -- | -- | 32 | 33.6 | 23.73 | 0.75 | 6 | 8 | 6 | 0 | 6 | 0 | 0 | 17.94 | 0 | 0 | 6 | 8 | 1 | 8 | 0 | 0 | 1 | 2 | 8 | 0 | 1 | 0 | 0.75 | 18 | 0 | 3 |
2019-01-09 | @ NOP | -- | -- | 20 | 20.8 | 20.22 | 0.56 | 5 | 9 | 0 | 0 | 0 | 0 | 0 | 19.11 | 0 | 0 | 5 | 9 | 4 | 4 | 0 | 2 | 4 | 0 | 8 | 1 | 0 | 0 | 0.56 | 10 | 0 | 1 |
2019-01-08 | vs. IND | -- | -- | 13.5 | 13.2 | 13.12 | 0 | 0 | 1 | 6 | 0 | 6 | 0 | 0 | 11.1 | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 6 | 0 | 4 |
2019-01-05 | vs. NOP | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-01-04 | vs. UTA | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-01-02 | vs. MIA | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-29 | @ ATL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-28 | @ MIA | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-26 | @ MEM | -- | -- | 22.25 | 21.2 | 21.55 | 0.25 | 2 | 8 | 2 | 0 | 2 | 0 | 0 | 19.56 | 0 | 0 | 2 | 8 | 2 | 11 | 0 | 2 | 2 | 0 | 6 | 0 | 1 | 1 | 0.25 | 6 | 0 | 4 |
2018-12-23 | vs. CHI | -- | -- | 8 | 9.9 | 12.77 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 10.43 | 0 | 0 | 0 | 3 | 2 | 2 | 0 | 1 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
2018-12-21 | @ TOR | -- | -- | 19 | 17.7 | 17.82 | 0.56 | 5 | 9 | 1 | 0 | 2 | 0 | 0 | 27.41 | 0 | 0 | 5 | 9 | 4 | 6 | 0 | 1 | 4 | 0 | 9 | 0 | 0.5 | 2 | 0.56 | 11 | 0 | 3 |
2018-12-19 | @ CHA | -- | -- | 16 | 17.8 | 15.5 | 0.75 | 3 | 4 | 1 | 0 | 3 | 0 | 0 | 13.73 | 0 | 0 | 3 | 4 | 1 | 4 | 0 | 0 | 1 | 0 | 5.5 | 2 | 0.33 | 0 | 0.75 | 7 | 0 | 0 |
2018-12-18 | @ IND | -- | -- | 11.5 | 11.8 | 13.9 | 0.33 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 13.41 | 0 | 0 | 1 | 3 | 0 | 4 | 0 | 2 | 0 | 0 | 3 | 1 | 0 | 1 | 0.33 | 2 | 0 | 1 |
2018-12-16 | vs. PHI | -- | -- | 12.5 | 12.9 | 17 | 0.75 | 3 | 4 | 1 | 0 | 2 | 0 | 0 | 14.61 | 0 | 0 | 3 | 4 | 2 | 2 | 0 | 1 | 2 | 1 | 6 | 0 | 0.5 | 1 | 0.75 | 7 | 0 | 0 |
2018-12-14 | vs. MIL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-12 | vs. NYK | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-10 | @ MIL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-08 | vs. WAS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-07 | vs. SAC | -- | -- | 5.75 | 5.6 | 4.63 | 0.5 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 17.28 | 0 | 0 | 1 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0.5 | 2 | 0 | 1 |
2018-12-05 | vs. GSW | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-03 | @ BKN | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-12-01 | vs. TOR | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-30 | @ BOS | -- | -- | 7 | 6.4 | 19.97 | 0.4 | 2 | 5 | 1 | 0 | 2 | 0 | 0 | 13.78 | 0 | 0 | 2 | 5 | 2 | 2 | 0 | 0 | 2 | 0 | 6 | 0 | 0.5 | 1 | 0.4 | 5 | 0 | 1 |
2018-11-28 | @ OKC | -- | -- | 8.75 | 8.5 | 13.03 | 0 | 0 | 4 | 0 | 0 | 2 | 0 | 0 | 22.13 | 0 | 0 | 0 | 4 | 1 | 5 | 0 | 1 | 1 | 0 | 5 | 1 | 0 | 2 | 0 | 0 | 0 | 2 |
2018-11-26 | vs. MIN | -- | -- | 2.5 | 2.4 | 4.6 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8.7 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
2018-11-24 | vs. HOU | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-23 | @ PHI | -- | -- | 0 | 0 | 0.57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-21 | vs. LAL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-19 | @ DET | -- | -- | 19 | 18.2 | 17.62 | 0.71 | 5 | 7 | 2 | 0 | 2 | 0 | 0 | 20.16 | 0 | 0 | 5 | 7 | 2 | 6 | 0 | 0 | 2 | 0 | 7 | 0 | 1 | 1 | 0.71 | 12 | 0 | 2 |
2018-11-14 | @ WAS | -- | -- | 7.25 | 7.1 | 15.07 | 1 | 1 | 1 | 0 | 0 | 2 | 0 | 0 | 5.87 | 0 | 0 | 1 | 1 | 5 | 3 | 0 | 1 | 5 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 1 |
2018-11-13 | vs. CHA | -- | -- | 2.25 | 0.6 | 6.18 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 25.89 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
2018-11-10 | @ CHI | -- | -- | 9 | 7.8 | 14.05 | 0.5 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 22.78 | 0 | 0 | 2 | 4 | 1 | 4 | 0 | 0 | 1 | 0 | 6 | 1 | 0 | 4 | 0.5 | 4 | 0 | 2 |
2018-11-07 | vs. OKC | -- | -- | 19.75 | 17.8 | 16.73 | 0.6 | 3 | 5 | 4 | 0 | 4 | 0 | 0 | 23.34 | 0 | 0 | 3 | 5 | 3 | 9 | 0 | 0 | 3 | 0 | 7 | 0 | 1 | 3 | 0.6 | 10 | 0 | 3 |
2018-11-05 | @ ORL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-03 | @ CHA | -- | -- | 4.5 | 4.4 | 4.38 | 0.5 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 18.26 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0.5 | 2 | 0 | 0 |
2018-11-01 | vs. DEN | -- | -- | 5.5 | 5.4 | 4.77 | 0.33 | 1 | 3 | 1 | 0 | 2 | 0 | 0 | 32.54 | 0 | 0 | 1 | 3 | 1 | 2 | 0 | 0 | 1 | 0 | 3 | 0 | 0.5 | 0 | 0.33 | 3 | 0 | 1 |
2018-10-30 | vs. ATL | -- | -- | 5.25 | 5.2 | 2.47 | 0.5 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 46.64 | 0 | 0 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0.5 | 4 | 0 | 1 |
2018-10-27 | vs. IND | -- | -- | 2.25 | 2.2 | 3.47 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 10.14 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0.5 | 0 | 0 | 1 | 0 | 1 |
2018-10-25 | @ DET | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-24 | vs. BKN | -- | -- | 2 | 1.4 | 4.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.93 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
2018-10-21 | vs. ATL | -- | -- | 6.75 | 5.6 | 3.42 | 0.5 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 70.18 | 0 | 0 | 2 | 4 | 1 | 3 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 2 | 0.5 | 4 | 0 | 2 |
2018-10-19 | @ MIN | -- | -- | 13.25 | 14.2 | 10.85 | 0.67 | 2 | 3 | 3 | 0 | 4 | 0 | 0 | 19.98 | 0 | 0 | 2 | 3 | 1 | 1 | 0 | 2 | 1 | 1 | 4 | 0 | 0.75 | 0 | 0.67 | 7 | 0 | 1 |
2018-10-17 | @ TOR | -- | -- | 14.4 | 1 | 2 | 2 | 1 | 0 | 2 | 0 | 0 | 9.83 | 0 | 0 | 2 | 2 | 2 | 3 | 0 | 2 | 2 | 0 | 3 | 0 | 0.5 | 0 | 1 | 5 | 0 | 0 |
Ante Zizic Daily Fantasy News, Rankings, Projections
Kevin Love (rest) and Ante Zizic (illness) out Tuesday; Larry Nance Jr. (knee) expected to play
Love and Zizic have officially been ruled out of Tuesday's second leg of a back-to-back set against the Los Angeles Clippers due to their respective ailments, while Nance Jr. is expected to return from a two-week absence recovering from a sore left knee. There haven't been any reports of a potential minute restriction for Nance, but even if he isn't able to handle a full starters' minute workload, he'll still be the leading candidate to receive the start at power forward this evening. Nance has been a solid fantasy point per minute contributor this season and throughout his career, so he'll be a viable value option in all formats barring some kind of severe restriction on his expected playing time. However, Cedi Osman has benefitted the most with Love, Zizic, and Kevin Porter Jr. off the court this season, he has a 18.8% usage rate and is averaging 0.94 DraftKings and 0.90 FanDuel points per minute in a 175.0 minutes sample size.
Dante Exum (illness) listed available Monday; Ante Zizic (illness) listed out
Exum has been upgraded from questionable on the latest Cavaliers injury report and will be available to play in Monday's matchup against the Los Angeles Lakers after missing one game due to an illness, while Zizic has been downgraded to out with an illness as well. In his absence, every Cleveland starter was allocated at least 34 minutes, and head coach John Beilein utilized a relatively tight rotation with Brandon Knight and Alfonzo McKinnie also recording at least 18 minutes off the bench. Exum has gradually been earning more playing time in Beilein's rotation, so Knight, McKinnie, and all the starters are unlikely to see similar minutes in tonight's contest as they did in Saturday's win.
Affordable Value
Tristan Thompson has already been ruled out today, while Larry Nance is questionable. If both are sidelined, the Cavs are very thin at power forward and center. Osman was no match on the interior in the last game. This would almost guarantee heavy minutes for Ante Zizic as the only healthy big man on the roster. He has been effective in previous stints when the minutes are there and will likely be a popular value. There's double-double potential with upside here.
Ante Zizic (foot) available to play Sunday; Larry Nance Jr. (thumb) listed out
As expected, Zizic will be available to make his season debut in Sunday's matchup against the Philadelphia 76ers after missing all 11 games thus far with left foot plantar fasciitis, while Nance Jr. will be sidelined due to a sprained left thumb. Zizic will be subject to a minute restriction of some kind, but the absence of Nance certainly does open up some available playing time in the frontcourt for Zizic and possibly even Kevin Love and Tristan Thompson this afternoon. Any other leftover minutes could trickle down to Alfonzo McKinnie at the forward positions, but both he and Zizic won't be in consideration for daily fantasy formats.
Per Coach Drew, Kevin Love won't play tonight against the Suns
Per Coach Drew, Kevin Love won't play tonight against the Suns. In a shootaround interview Drew noted that there would be "no Kevin" tonight, so we should see plenty of Larry Nance with Tristan Thompson, Marquese Chriss and Ante Zizic both options to see more time against a leaky Suns front-court. Phoenix has been a sieve to opposing bigs all year, so this is a nice spot for the Cleveland bigs. Both the Cavs and Suns are ranked towards the very bottom of the league in defensive efficiency.
Fire Up Mr. Zizic
I fully expect the Cavaliers to get blown out tonight, but that shouldn't impact the fantasy production of Ante Zizic. The Cavaliers are very short-handed tonight -- Kevin Love will be rested, Tristan Thompson and Larry Nance are both doubtful, and Marquese Chriss is likely to get suspended. Zizic should play close to 30 minutes regardless of the game's outcome. He was the king of garbage time earlier in the season and I expect that to be the case again tonight.
Obvious Value
This team might be woefully short on big men tonight. Kevin Love is resting. Nance and Thompson are hurt and questionable at best tonight. Chriss might be looking at a suspension after a fight with Serge Ibaka yesterday. Ante Zizic might be the last man standing, and he put up a 17/7 line in last night's game. He will be one of the most popular options on the slate, but we need to get clarity on who will be active.
Ante Zizic (concussion) available to play Friday
Zizic has officially been upgraded from questionable and will be available to play in Friday's matchup against the Miami Heat after missing three consecutive games due to concussion-like symptoms, while Tristan Thompson continues to be sidelined by a sore left foot. In Zizic's absence, Larry Nance was a bit inconsistent from a fantasy perspective but did log at least 32 minutes in two of his most recent spot starts. Now that Zizic is available, it's possible Nance heads back to resume a reserve role, though it's unlikely he sees a drastic reduction in playing time since he rarely logs fewer than 25 minutes regardless of anchoring the first or second units in head coach Larry Drew's frontcourt rotation.
Ante Zizic (concussion) and Tristan Thompson (foot) listed out Sunday
Zizic has been listed as out on the most recent version of the Cavalier's injury report and won't play in Sunday's matchup against the Orlando Magic due to a concussion that has now forced him to miss two consecutive games, while Thompson remains sidelined with a sore left foot and is still without a timetable for a return. However, Cleveland will see some reinforcements with Kevin Love set to return from a one-game absence for rest purposes, and he'll almost certainly reclaim his typical spot in the starting frontcourt, which will send with Marquese Chriss or Larry Nance back to the bench to resume a reserve role, though both are likely to see similar minutes regardless of starting lineup.
Cedi Osman (ankle) and Ante Zizic (back) listed as available Wednesday
Osman and Zizic have both been upgraded from questionable on the most recent version of the Cavaliers' injury report and are listed as available to play in Wednesday's matchup against the Brooklyn Nets, while Kevin Love has already been ruled out for rest purposes as part of his return from injury management plan. Love has played in two games since returning from a foot injury that kept him sidelined for 50 games, but he’s yet to log more than 16 minutes in either contest, making his absence a bit less meaningful this evening. The last time Love was rested, Marquese Chriss drew the start alongside Larry Nance in the frontcourt, and he’s been serviceable from a fantasy perspective in an average of 23.1 minutes over the previous three games. There's been no word of a potential minute restriction for Osman, so he'll presumably replace Brandon Knight, who logged 16 minutes in his first spot start, in the starting lineup, assuming head coach Larry Drew rolls with Chriss at center once again.